Prevalence and laboratorial determinants of the clinical relevance of antibodies of undetermined specificity

Imagem de Miniatura
Arquivos
art_CONRADO_Prevalence_and_laboratorial_determinants_of_the_clinical_relevance_2019.PDF (285.25 KB)
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
CARDOSO, Regina A.
Citação
VOX SANGUINIS, v.114, n.6, p.616-621, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background and Objectives Antibodies of unknown specificity (AUS) are frequently identified in the pre-transfusion testing. These antibodies can be insignificant or potentially cause post-transfusion haemolysis. Information about the prevalence of clinically relevant AUS is still lacking. Our aim was to predict the potential clinical relevance of AUS using the monocyte monolayer assay (MMA) and to identify the clinical and laboratorial determinants of AUS' significance. Materials and Methods Antibodies of unknown specificity identified at a single institution from 2015-2017 were evaluated through MMA. A monocyte index (MI) of more than 5% was predictive of potential post-transfusion haemolysis. Results Thirty-two patients with AUS were included in the study. Of the studied AUS, 37 center dot 5% (12/32) presented with a monocyte index (MI) more than 5%. In the group of significant AUS, 41 center dot 7% of the patients presented with sickle cell disease (SCD) and the AUS were associated with Rh antibodies in 75% of the cases. In the group of insignificant AUS, only 10% of the patients had SCD and the association with Rh antibodies was detected in 20% of the cases. The presence of Rh antibodies was independently associated with the AUS clinical relevance (P = 0 center dot 012). Conclusion More than one-third of the AUS are potentially clinically relevant, and the association with Rh antibodies is predictive of AUS relevance. Services must honour AUS in the pre-transfusion process in order to ensure transfusion safety.
Palavras-chave
antibodies of undetermined specificity, monocyte monolayer assay, post-transfusion haemolytic reactions, Rh
URI
https://observatorio.fm.usp.br/handle/OPI/33454
Referências
  1. AABB, TECHNICAL MANUAL
  2. Arndt PA, 2004, TRANSFUSION, V44, P1273, DOI 10.1111/j.1537-2995.2004.03427.x
  3. BECK ML, 1984, MED LAB SCI, V41, P374
  4. Conrado MCAV, 2018, J CLIN LAB ANAL, V32, DOI 10.1002/jcla.22274
  5. Dezan MR, 2017, BLOOD CELL MOL DIS, V65, P8, DOI 10.1016/j.bcmd.2017.03.014
  6. Eichler H, 1999, VOX SANG, V77, P154, DOI 10.1046/j.1423-0410.1999.7730154.x
  7. LAPIERRE Y, 1990, TRANSFUSION, V30, P109, DOI 10.1046/j.1537-2995.1990.30290162894.x
  8. Legler TJ, 2001, TRANSFUSION MED, V11, P383, DOI 10.1046/j.1365-3148.2001.00327.x
  9. Liu C, 2013, TRANSFUSION, V53, P931, DOI 10.1111/trf.12070
  10. Mushkbar M, 2013, VOX SANG, V105, P341, DOI 10.1111/vox.12059
  11. Noumsi GT, 2015, TRANSFUSION MED, V25, P92, DOI 10.1111/tme.12189
  12. Tormey CA, 2013, TRANSFUSION, V53, P926, DOI 10.1111/trf.12147

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - IMT
Carregar mais